

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 5.99838717 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.96142072 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.73036196 |
| 4 | macrophage activation involved in immune response (GO:0002281) | 5.20905598 |
| 5 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.73347935 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.66524566 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.66524566 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.66524566 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.66524566 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.66524566 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.66524566 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.52809864 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.52809864 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.48127555 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 4.47645250 |
| 16 | germinal center formation (GO:0002467) | 4.46960047 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.45303967 |
| 18 | defense response to protozoan (GO:0042832) | 4.39409499 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.27362857 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.20060003 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.17849687 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.15224625 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 4.13632546 |
| 24 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.13087147 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.08360519 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.06933243 |
| 27 | detection of other organism (GO:0098543) | 4.04584234 |
| 28 | response to protozoan (GO:0001562) | 3.98703724 |
| 29 | B cell proliferation (GO:0042100) | 3.97215725 |
| 30 | response to peptidoglycan (GO:0032494) | 3.96322789 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90346853 |
| 32 | detection of molecule of bacterial origin (GO:0032490) | 3.84855074 |
| 33 | detection of bacterium (GO:0016045) | 3.84301216 |
| 34 | regulation of B cell differentiation (GO:0045577) | 3.79371516 |
| 35 | positive regulation of interferon-alpha production (GO:0032727) | 3.76880355 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 3.74193823 |
| 37 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.73903915 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 3.73629158 |
| 39 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.65758967 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.65668093 |
| 41 | NIK/NF-kappaB signaling (GO:0038061) | 3.65666459 |
| 42 | regulation of antigen processing and presentation (GO:0002577) | 3.64852842 |
| 43 | B cell mediated immunity (GO:0019724) | 3.61043219 |
| 44 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.57899677 |
| 45 | type I interferon signaling pathway (GO:0060337) | 3.56182789 |
| 46 | cellular response to type I interferon (GO:0071357) | 3.56182789 |
| 47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.55252398 |
| 48 | response to type I interferon (GO:0034340) | 3.53662801 |
| 49 | B cell homeostasis (GO:0001782) | 3.53299866 |
| 50 | positive thymic T cell selection (GO:0045059) | 3.48287708 |
| 51 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.47918703 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.47918703 |
| 53 | macrophage activation (GO:0042116) | 3.43238352 |
| 54 | cellular extravasation (GO:0045123) | 3.40292561 |
| 55 | positive regulation of B cell proliferation (GO:0030890) | 3.39261877 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.37440406 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35330433 |
| 58 | neutrophil activation (GO:0042119) | 3.31147728 |
| 59 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.27596792 |
| 60 | positive regulation of type 2 immune response (GO:0002830) | 3.25837780 |
| 61 | regulation of B cell proliferation (GO:0030888) | 3.25376977 |
| 62 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.25066969 |
| 63 | granulocyte activation (GO:0036230) | 3.22880765 |
| 64 | positive regulation of B cell activation (GO:0050871) | 3.22731292 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.21441027 |
| 66 | T-helper 1 type immune response (GO:0042088) | 3.19407928 |
| 67 | leukocyte aggregation (GO:0070486) | 3.19160600 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.15749877 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.15228607 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14241036 |
| 71 | microglial cell activation (GO:0001774) | 3.12639321 |
| 72 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12011582 |
| 73 | response to host immune response (GO:0052572) | 3.12011582 |
| 74 | regulation of mast cell degranulation (GO:0043304) | 3.04808144 |
| 75 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.01950664 |
| 76 | T cell lineage commitment (GO:0002360) | 3.00820154 |
| 77 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.00411881 |
| 78 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.00384703 |
| 79 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.99923111 |
| 80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.99605894 |
| 81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97314857 |
| 82 | respiratory burst (GO:0045730) | 2.96493679 |
| 83 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90803026 |
| 84 | positive regulation of protein homooligomerization (GO:0032464) | 2.90757979 |
| 85 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.89547011 |
| 86 | regulation of germinal center formation (GO:0002634) | 2.87656270 |
| 87 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.87066903 |
| 88 | positive regulation of interferon-beta production (GO:0032728) | 2.86499928 |
| 89 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86496492 |
| 90 | response to host (GO:0075136) | 2.86496492 |
| 91 | response to host defenses (GO:0052200) | 2.86496492 |
| 92 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.85525991 |
| 93 | positive regulation of Rap GTPase activity (GO:0032854) | 2.84752926 |
| 94 | negative regulation of B cell proliferation (GO:0030889) | 2.84018467 |
| 95 | T cell selection (GO:0045058) | 2.83369837 |
| 96 | positive regulation of mast cell activation (GO:0033005) | 2.82441860 |
| 97 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.80564804 |
| 98 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80192949 |
| 99 | T cell migration (GO:0072678) | 2.79109430 |
| 100 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.78728406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.89836401 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.19611104 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.13893113 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.99073340 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.72190022 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.68631243 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.48725440 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42545420 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.32974513 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.31445638 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.18151770 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10735764 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.91281683 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89243189 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.83107685 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75714181 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.72733615 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 2.70203786 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.69823918 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.61400377 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56479527 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.50853379 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.45301969 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.39177736 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34460880 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.32446380 |
| 27 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.25887675 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 2.24533691 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20338824 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16371948 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.09385152 |
| 32 | UTX_26944678_Chip-Seq_JUKART_Human | 2.06664373 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 2.03995962 |
| 34 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.00433554 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97179278 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97114297 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.94145658 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89826547 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85669478 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82821929 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82817852 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82585794 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.81142558 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.73809604 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71844981 |
| 46 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.68721797 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.68638778 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64172135 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63502128 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62963156 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54572382 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.52227137 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49914922 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46352778 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46301692 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46001773 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34636127 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34475383 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29601061 |
| 60 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29481966 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26592734 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26048123 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25220101 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.24418579 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21109301 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19241623 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16636390 |
| 68 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15550317 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15405149 |
| 70 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14714654 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14540362 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09935003 |
| 73 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07981538 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01432811 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00631836 |
| 76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99901059 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99022653 |
| 78 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96571464 |
| 79 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96083756 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94789684 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93557907 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92773666 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91316572 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90352780 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88897221 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88583817 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87420683 |
| 88 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87239756 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87130370 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86718564 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85958127 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85797961 |
| 93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85226645 |
| 94 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84727860 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83165445 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82032210 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81473498 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80229174 |
| 99 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.78642868 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77491880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.47654885 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.27604028 |
| 3 | MP0001800_abnormal_humoral_immune | 3.52320272 |
| 4 | MP0005387_immune_system_phenotype | 3.50187460 |
| 5 | MP0001790_abnormal_immune_system | 3.50187460 |
| 6 | MP0003436_decreased_susceptibility_to | 3.29405030 |
| 7 | MP0003724_increased_susceptibility_to | 3.19609265 |
| 8 | MP0000685_abnormal_immune_system | 3.12356488 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.10544200 |
| 10 | MP0005671_abnormal_response_to | 2.99180866 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.88815476 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.79128749 |
| 13 | MP0002723_abnormal_immune_serum | 2.77838336 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.61851238 |
| 15 | MP0009785_altered_susceptibility_to | 2.58075438 |
| 16 | MP0001819_abnormal_immune_cell | 2.58023488 |
| 17 | MP0002419_abnormal_innate_immunity | 2.55103369 |
| 18 | MP0005025_abnormal_response_to | 2.50597139 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.40911273 |
| 20 | MP0002398_abnormal_bone_marrow | 2.23307423 |
| 21 | MP0005310_abnormal_salivary_gland | 2.17237753 |
| 22 | MP0005451_abnormal_body_composition | 2.09935274 |
| 23 | MP0000716_abnormal_immune_system | 2.09626838 |
| 24 | MP0002405_respiratory_system_inflammati | 2.04179414 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.98316330 |
| 26 | MP0000689_abnormal_spleen_morphology | 1.91446364 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.86545818 |
| 28 | MP0008057_abnormal_DNA_replication | 1.85617372 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.83422420 |
| 30 | MP0004947_skin_inflammation | 1.82863343 |
| 31 | MP0001853_heart_inflammation | 1.75512189 |
| 32 | MP0009278_abnormal_bone_marrow | 1.75511849 |
| 33 | MP0002722_abnormal_immune_system | 1.75241058 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.73947991 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.72675454 |
| 36 | MP0006082_CNS_inflammation | 1.70923935 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.70888504 |
| 38 | MP0002429_abnormal_blood_cell | 1.67812290 |
| 39 | MP0004510_myositis | 1.58569148 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.50855349 |
| 41 | MP0001873_stomach_inflammation | 1.50461233 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.48076944 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.47593118 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.45885601 |
| 45 | MP0009764_decreased_sensitivity_to | 1.43302799 |
| 46 | MP0004381_abnormal_hair_follicle | 1.42424583 |
| 47 | MP0002009_preneoplasia | 1.38391551 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.36111848 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.36111848 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.32716493 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.31108604 |
| 52 | MP0008469_abnormal_protein_level | 1.28173659 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.26182101 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.23701586 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.22075923 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.20146776 |
| 57 | MP0008260_abnormal_autophagy | 1.16349778 |
| 58 | MP0002132_abnormal_respiratory_system | 1.11219488 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.10201275 |
| 60 | MP0008004_abnormal_stomach_pH | 1.08912951 |
| 61 | MP0000858_altered_metastatic_potential | 1.05478058 |
| 62 | MP0003866_abnormal_defecation | 1.05179450 |
| 63 | MP0005166_decreased_susceptibility_to | 1.01498060 |
| 64 | MP0003091_abnormal_cell_migration | 1.01190283 |
| 65 | MP0000490_abnormal_crypts_of | 0.96863729 |
| 66 | MP0001663_abnormal_digestive_system | 0.93926676 |
| 67 | MP0002006_tumorigenesis | 0.93158654 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.92527166 |
| 69 | MP0003075_altered_response_to | 0.92149556 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.88166358 |
| 71 | MP0003448_altered_tumor_morphology | 0.86554070 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.86272229 |
| 73 | MP0002019_abnormal_tumor_incidence | 0.85666665 |
| 74 | MP0004883_abnormal_blood_vessel | 0.85131422 |
| 75 | MP0002254_reproductive_system_inflammat | 0.84042983 |
| 76 | MP0003828_pulmonary_edema | 0.77469312 |
| 77 | MP0000604_amyloidosis | 0.77141547 |
| 78 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76506855 |
| 79 | MP0009840_abnormal_foam_cell | 0.76211771 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.75248023 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.74978706 |
| 82 | MP0003690_abnormal_glial_cell | 0.74661151 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.74482593 |
| 84 | MP0002332_abnormal_exercise_endurance | 0.74286927 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.73546977 |
| 86 | MP0000343_altered_response_to | 0.69053849 |
| 87 | MP0009763_increased_sensitivity_to | 0.68798353 |
| 88 | MP0002933_joint_inflammation | 0.68318007 |
| 89 | MP0001851_eye_inflammation | 0.68309697 |
| 90 | MP0010307_abnormal_tumor_latency | 0.66117959 |
| 91 | MP0003045_fibrosis | 0.66110910 |
| 92 | MP0000249_abnormal_blood_vessel | 0.65983384 |
| 93 | MP0010094_abnormal_chromosome_stability | 0.64800493 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.63071997 |
| 95 | MP0005164_abnormal_response_to | 0.62135504 |
| 96 | MP0008874_decreased_physiological_sensi | 0.56449612 |
| 97 | MP0000313_abnormal_cell_death | 0.56442021 |
| 98 | MP0000371_diluted_coat_color | 0.55010394 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.54982247 |
| 100 | MP0005381_digestive/alimentary_phenotyp | 0.53811523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 5.92305368 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.26563204 |
| 3 | Meningitis (HP:0001287) | 5.15106987 |
| 4 | Colitis (HP:0002583) | 4.90477702 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.90151829 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.88903801 |
| 7 | Eczematoid dermatitis (HP:0000976) | 4.79277871 |
| 8 | Gastrointestinal stroma tumor (HP:0100723) | 4.74505009 |
| 9 | Cellulitis (HP:0100658) | 4.62413734 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 4.47693755 |
| 11 | Recurrent viral infections (HP:0004429) | 4.45806556 |
| 12 | Vasculitis (HP:0002633) | 4.10843169 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.08363419 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 4.06005314 |
| 15 | Optic neuritis (HP:0100653) | 4.06005314 |
| 16 | Inflammation of the large intestine (HP:0002037) | 4.04495056 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.99463952 |
| 18 | Orchitis (HP:0100796) | 3.96137459 |
| 19 | Gastrointestinal inflammation (HP:0004386) | 3.93549200 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.87641017 |
| 21 | Myositis (HP:0100614) | 3.84780232 |
| 22 | Recurrent sinusitis (HP:0011108) | 3.78544298 |
| 23 | Lymphopenia (HP:0001888) | 3.70207912 |
| 24 | Encephalitis (HP:0002383) | 3.68559153 |
| 25 | Obstructive lung disease (HP:0006536) | 3.54609608 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.54609608 |
| 27 | Recurrent bronchitis (HP:0002837) | 3.54524335 |
| 28 | Recurrent skin infections (HP:0001581) | 3.53367761 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52665772 |
| 30 | IgM deficiency (HP:0002850) | 3.52665028 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.51283937 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.51283937 |
| 33 | Verrucae (HP:0200043) | 3.49983697 |
| 34 | Papilloma (HP:0012740) | 3.49983697 |
| 35 | B lymphocytopenia (HP:0010976) | 3.40687048 |
| 36 | Osteomyelitis (HP:0002754) | 3.40582581 |
| 37 | Stomatitis (HP:0010280) | 3.37080103 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.36836863 |
| 39 | Abnormality of B cell number (HP:0010975) | 3.24259264 |
| 40 | T lymphocytopenia (HP:0005403) | 3.12544566 |
| 41 | Sepsis (HP:0100806) | 3.11664218 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 3.07521778 |
| 43 | Recurrent pneumonia (HP:0006532) | 3.06768427 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 3.04366601 |
| 45 | Spontaneous hematomas (HP:0007420) | 3.03599008 |
| 46 | Viral hepatitis (HP:0006562) | 3.01621223 |
| 47 | Increased IgE level (HP:0003212) | 2.94204824 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.93826597 |
| 49 | Emphysema (HP:0002097) | 2.91750138 |
| 50 | Restrictive lung disease (HP:0002091) | 2.86138056 |
| 51 | Recurrent lower respiratory tract infections (HP:0002783) | 2.84023247 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.83853500 |
| 53 | Keratoconjunctivitis (HP:0001096) | 2.77590633 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.69659036 |
| 55 | Abnormality of T cells (HP:0002843) | 2.67302105 |
| 56 | Gingivitis (HP:0000230) | 2.66606232 |
| 57 | Lymphoma (HP:0002665) | 2.66363379 |
| 58 | Hemoptysis (HP:0002105) | 2.63373734 |
| 59 | Abnormality of the pleura (HP:0002103) | 2.58769422 |
| 60 | IgA deficiency (HP:0002720) | 2.57915932 |
| 61 | Urticaria (HP:0001025) | 2.57544716 |
| 62 | Chest pain (HP:0100749) | 2.56316113 |
| 63 | Abnormality of the peritoneum (HP:0002585) | 2.49094866 |
| 64 | Abnormality of the prostate (HP:0008775) | 2.43295096 |
| 65 | IgG deficiency (HP:0004315) | 2.42340922 |
| 66 | Gangrene (HP:0100758) | 2.35469883 |
| 67 | Granulocytopenia (HP:0001913) | 2.30563434 |
| 68 | Combined immunodeficiency (HP:0005387) | 2.30223006 |
| 69 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28461732 |
| 70 | Chronic otitis media (HP:0000389) | 2.26072808 |
| 71 | Leukocytosis (HP:0001974) | 2.25405872 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.24980944 |
| 73 | Skin rash (HP:0000988) | 2.24303240 |
| 74 | Hypoplasia of the thymus (HP:0000778) | 2.24146604 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.21172523 |
| 76 | Arterial thrombosis (HP:0004420) | 2.19101749 |
| 77 | Pulmonary embolism (HP:0002204) | 2.18388815 |
| 78 | Increased IgM level (HP:0003496) | 2.15313966 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 2.12952877 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.08871485 |
| 81 | Epistaxis (HP:0000421) | 2.07891186 |
| 82 | Chronic diarrhea (HP:0002028) | 2.07153631 |
| 83 | Leukopenia (HP:0001882) | 2.06972115 |
| 84 | Eosinophilia (HP:0001880) | 2.05785616 |
| 85 | Skin ulcer (HP:0200042) | 2.04622247 |
| 86 | Arthralgia (HP:0002829) | 2.04597638 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 2.04386544 |
| 88 | Anorexia (HP:0002039) | 2.00196307 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 1.99751133 |
| 90 | Hematochezia (HP:0002573) | 1.99420680 |
| 91 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.96746802 |
| 92 | Pustule (HP:0200039) | 1.94591014 |
| 93 | Abnormality of the fingertips (HP:0001211) | 1.94100117 |
| 94 | Slow saccadic eye movements (HP:0000514) | 1.93373086 |
| 95 | Polyneuropathy (HP:0001271) | 1.92303095 |
| 96 | Chronic sinusitis (HP:0011109) | 1.91037880 |
| 97 | Loss of speech (HP:0002371) | 1.89123834 |
| 98 | Thyroiditis (HP:0100646) | 1.87280269 |
| 99 | Glomerulopathy (HP:0100820) | 1.87170842 |
| 100 | Bronchitis (HP:0012387) | 1.83793270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.70694269 |
| 2 | RIPK4 | 4.59141523 |
| 3 | ERN1 | 3.86428817 |
| 4 | BLK | 3.84566634 |
| 5 | MAP3K10 | 3.47876771 |
| 6 | IRAK4 | 3.05419154 |
| 7 | MAP3K14 | 2.57936515 |
| 8 | PRPF4B | 2.55626757 |
| 9 | TYK2 | 2.31253654 |
| 10 | SYK | 2.20983975 |
| 11 | BTK | 2.20932507 |
| 12 | NME2 | 1.93379889 |
| 13 | MAP3K13 | 1.93046832 |
| 14 | IKBKE | 1.87029120 |
| 15 | CSK | 1.83603701 |
| 16 | MAP2K3 | 1.74260589 |
| 17 | TXK | 1.73188346 |
| 18 | BMPR2 | 1.70851539 |
| 19 | TBK1 | 1.64820509 |
| 20 | LYN | 1.58366981 |
| 21 | IKBKB | 1.53073480 |
| 22 | FES | 1.48924806 |
| 23 | CSF1R | 1.43482269 |
| 24 | IRAK2 | 1.42549058 |
| 25 | TNK2 | 1.41984265 |
| 26 | FGR | 1.40642312 |
| 27 | HCK | 1.37672211 |
| 28 | SIK3 | 1.35810984 |
| 29 | GRK6 | 1.33759860 |
| 30 | JAK3 | 1.33545322 |
| 31 | IRAK3 | 1.24443061 |
| 32 | CDK4 | 1.22677054 |
| 33 | JAK1 | 1.17429824 |
| 34 | ZAP70 | 1.12276645 |
| 35 | TAOK1 | 1.11820298 |
| 36 | CDC42BPA | 1.09406263 |
| 37 | MARK3 | 1.08266741 |
| 38 | TEC | 1.08160521 |
| 39 | MAP3K11 | 1.07733952 |
| 40 | IRAK1 | 1.06799068 |
| 41 | SIK2 | 1.05909344 |
| 42 | JAK2 | 1.04233772 |
| 43 | MAP3K1 | 1.03421509 |
| 44 | TAOK2 | 1.02935815 |
| 45 | CDK12 | 1.00621831 |
| 46 | MATK | 0.99049630 |
| 47 | STK10 | 0.99031877 |
| 48 | TRIB3 | 0.94073072 |
| 49 | MAP3K3 | 0.93138708 |
| 50 | LCK | 0.91774571 |
| 51 | MAPK11 | 0.87346511 |
| 52 | PIM1 | 0.87217874 |
| 53 | MARK2 | 0.83933993 |
| 54 | CHUK | 0.83293896 |
| 55 | NLK | 0.81631859 |
| 56 | ITK | 0.80820188 |
| 57 | KSR2 | 0.77588239 |
| 58 | TAOK3 | 0.75969474 |
| 59 | MAPK12 | 0.75180825 |
| 60 | PDK1 | 0.70463676 |
| 61 | MAPK7 | 0.67188490 |
| 62 | PRKCQ | 0.66500216 |
| 63 | SMG1 | 0.66452804 |
| 64 | TLK1 | 0.59545588 |
| 65 | BRD4 | 0.55665221 |
| 66 | MELK | 0.54469397 |
| 67 | MAP3K8 | 0.54176655 |
| 68 | LRRK2 | 0.53808654 |
| 69 | KIT | 0.53451953 |
| 70 | ACVR1B | 0.52720543 |
| 71 | CDK6 | 0.52426933 |
| 72 | TESK2 | 0.52141480 |
| 73 | MAPK4 | 0.50718737 |
| 74 | PDPK1 | 0.49662912 |
| 75 | STK24 | 0.49124191 |
| 76 | PIK3CG | 0.47539464 |
| 77 | GRK7 | 0.44872329 |
| 78 | MST4 | 0.41723763 |
| 79 | YES1 | 0.41536932 |
| 80 | MAP3K5 | 0.41389474 |
| 81 | FYN | 0.39984761 |
| 82 | NEK9 | 0.39440886 |
| 83 | HIPK2 | 0.39248556 |
| 84 | DYRK1B | 0.39228545 |
| 85 | TGFBR2 | 0.38393897 |
| 86 | MAPKAPK2 | 0.37958757 |
| 87 | SIK1 | 0.36687464 |
| 88 | ABL1 | 0.34780574 |
| 89 | MAP2K2 | 0.33853846 |
| 90 | EIF2AK3 | 0.33292153 |
| 91 | RPS6KC1 | 0.32464242 |
| 92 | RPS6KL1 | 0.32464242 |
| 93 | FGFR3 | 0.29278704 |
| 94 | CLK1 | 0.28097879 |
| 95 | STK4 | 0.26855842 |
| 96 | RPS6KA6 | 0.24071188 |
| 97 | SGK3 | 0.23633160 |
| 98 | ICK | 0.20119773 |
| 99 | RPS6KB1 | 0.19965591 |
| 100 | MAPK3 | 0.19602313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.31152933 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.27063437 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.09577584 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.05347348 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.04242353 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.98731759 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.88476628 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.80131134 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79089316 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52296223 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.47468574 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43606416 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.41677639 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.10538465 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09916878 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.09152553 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.84819571 |
| 18 | Influenza A_Homo sapiens_hsa05164 | 1.81408408 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79958968 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.74046095 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68832768 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56514825 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55768417 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52734874 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.51805083 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49829718 |
| 27 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.47050568 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.44488687 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42158466 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40297564 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36753060 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.34930346 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.32843795 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28299572 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25489049 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.22982498 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18034603 |
| 38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16648217 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13662197 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12324078 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05682684 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.04866132 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04323830 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.01343609 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.01070372 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 0.98454323 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.97909705 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.95288557 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91212506 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88991592 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85299049 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78128479 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74120858 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73874136 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70687296 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66820681 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.66406861 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66390198 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.63317111 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63133435 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.61686885 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61175260 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60436565 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59750813 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59593771 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58382173 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57009944 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.56181334 |
| 69 | Prostate cancer_Homo sapiens_hsa05215 | 0.55954112 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53426091 |
| 71 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50125238 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.49136367 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47540000 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46370726 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46153549 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42803240 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42271750 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41451823 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41251382 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.40668384 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39865022 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39690727 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38164496 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36358267 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.36207617 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35323410 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34593668 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34338496 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34283909 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.32450208 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30602821 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30052701 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29765665 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.29396369 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27767798 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19553178 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.16614003 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.15668388 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14645269 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.12499359 |

